Abstract
H. Iwata*1, N. Masuda2, T. Toyama3, N. Taira4, Y. Yamamoto5, S. Saji6, M. Kashiwaba7, T. Yamaguchi8, Y. Ohashi9 1Breast Oncology, Aichi Cancer Center Hospital, Nagoya, 2Surgery, NHO Osaka National Hospital, Osaka, 3Breast and Endocrine Surgery, Nagoya City University Hospital, Nagoya, 4Breast and Endocrine Surgery, Okayama University Hospital, Okayama, 5Breast and Endocrine Surgery, Kumamoto University Hospital, Kumamoto, 6Breast Oncology Unit, Tokyo Metropolitan Cancer and Infection disease Center Komagome Hospital, Tokyo, 7Surgery, Iwate Medical University, Morioka, 8Clinical Trial Data Management, 9Biostatistics, School of Public Health, The University of Tokyo, Tokyo, Japan CSPOR
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
